The Committee for Medicinal Products for Human Use (CHMP) is the European Medicines Agency's (EMA) committee responsible for human medicines. It plays a vital role in the …

The European Medicines Agency (EMA) publishes details of the members and alternates of its Committee for Medicinal Products for Human Use (CHMP).

Apr 25, 2024 · EMA’s human medicines committee (CHMP) recommended eight medicines for approval at its April 2024 meeting. The CHMP recommended granting a marketing …

The committee that is responsible for preparing the Agency's opinions on questions concerning human medicines. Abbreviated as CHMP. More information can be found under 'Committee …

developed a multi-annual workplan on AI to enable the safe and responsible use of AI in the medicine lifecycle and extract value for public and animal health. In addition, the EMRN …

Dec 12, 2024 · EMA’s human medicines committee (CHMP) recommended seventeen medicines for approval at its December 2024 meeting. This brings the total number of medicines …

The Committee for Medicinal Products for Human Use (Committee), being part of the Agency, is responsible for preparing the opinion of the Agency on any question relating to the evaluation …

Jan 25, 2024 · EMA’s human medicines committee (CHMP) recommended three medicines for approval at its January 2024 meeting.

Jul 15, 2024 · EMA guidance documents on the use of medicinal products for treatment in case of exposure to Biological or Chemical agents used as weapons of terrorism, crime, or …

Nov 14, 2024 · EMA’s human medicines committee (CHMP) recommended eight medicines for approval at its November 2024 meeting. The committee recommended granting a conditional …